126 related articles for article (PubMed ID: 9658313)
1. Clinical significance of serum levels of CD44 variant exons 8-10 protein in colorectal cancer.
Yamaguchi A; Goi T; Taguchi S; Ohtaki N; Seki K; Hirose K; Nakagawara G; Urano T; Furukawa K
J Gastroenterol; 1998 Jun; 33(3):349-53. PubMed ID: 9658313
[TBL] [Abstract][Full Text] [Related]
2. Expression of a CD44 variant containing exons 8 to 10 is a useful independent factor for the prediction of prognosis in colorectal cancer patients.
Yamaguchi A; Urano T; Goi T; Saito M; Takeuchi K; Hirose K; Nakagawara G; Shiku H; Furukawa K
J Clin Oncol; 1996 Apr; 14(4):1122-7. PubMed ID: 8648366
[TBL] [Abstract][Full Text] [Related]
3. Expression of variant CD44 containing variant exon v8-10 in gallbladder cancer.
Yamaguchi A; Zhang M; Goi T; Fujita T; Niimoto S; Katayama K; Hirose K
Oncol Rep; 2000; 7(3):541-4. PubMed ID: 10767365
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resection.
Yamaguchi A; Goi T; Seki K; Ohtaki N; Maehara M; Kobayashi T; Niimoto S; Katayama K; Hirose K; Nakagawara G; Matsukawa S
Oncology; 1998; 55(5):400-3. PubMed ID: 9732216
[TBL] [Abstract][Full Text] [Related]
5. Expression of CD44 variant exons 8-10 in gastric cancer.
Yamaguchi A; Saito M; Gio T; Iida A; Takeuchi K; Hirose K; Nakagawara G; Urano T; Furukawa K; Shiku H
Jpn J Cancer Res; 1995 Dec; 86(12):1166-71. PubMed ID: 8636005
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
7. Relationship between indoleamine 2,3-dioxygenase activity and lymphatic invasion propensity of colorectal carcinoma.
Engin A; Gonul II; Engin AB; Karamercan A; Sepici Dincel A; Dursun A
World J Gastroenterol; 2016 Apr; 22(13):3592-601. PubMed ID: 27053851
[TBL] [Abstract][Full Text] [Related]
8. [Expression of variant CD44 in colorectal cancer and its relationship to liver metastasis].
Yamaguchi A
Nihon Geka Gakkai Zasshi; 1998 Jul; 99(7):409-14. PubMed ID: 9742519
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer.
Yamane N; Tsujitani S; Makino M; Maeta M; Kaibara N
Oncology; 1999 Apr; 56(3):232-8. PubMed ID: 10202279
[TBL] [Abstract][Full Text] [Related]
10. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients.
Stickeler E; Vogl FD; Denkinger T; Mobus VJ; Kreienberg R; Runnebaum IB
Int J Mol Med; 2000 Nov; 6(5):595-601. PubMed ID: 11029531
[TBL] [Abstract][Full Text] [Related]
12. Loss of standard type of CD44 expression in invaded area as a good indicator of lymph-node metastasis in colorectal carcinoma.
Asao T; Nakamura J; Shitara Y; Tsutsumi S; Mochiki E; Shimura T; Takenoshita S; Kuwano H
Dis Colon Rectum; 2000 Sep; 43(9):1250-4; discussion 1254-5. PubMed ID: 11005492
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD44 isoforms in serum as potential markers of metastatic gastric carcinoma.
Harn HJ; Ho LI; Shyu RY; Yuan JS; Lin FG; Young TH; Liu CA; Tang HS; Lee WH
J Clin Gastroenterol; 1996 Mar; 22(2):107-10. PubMed ID: 8742647
[TBL] [Abstract][Full Text] [Related]
14. Increased soluble CD44 concentrations are associated with larger tumor size and lymph node metastasis in breast cancer patients.
Mayer S; zur Hausen A; Watermann DO; Stamm S; Jäger M; Gitsch G; Stickeler E
J Cancer Res Clin Oncol; 2008 Nov; 134(11):1229-35. PubMed ID: 18438684
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.
Amirghofran Z; Jalali SA; Hosseini SV; Vasei M; Sabayan B; Ghaderi A
J Gastrointest Cancer; 2008; 39(1-4):73-8. PubMed ID: 19333790
[TBL] [Abstract][Full Text] [Related]
16. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
17. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
[No Abstract] [Full Text] [Related]
18. Histopathologic characteristics of colorectal cancer with liver metastasis.
Adachi Y; Inomata M; Kakisako K; Sato K; Shiraishi N; Kitano S
Dis Colon Rectum; 1999 Aug; 42(8):1053-6. PubMed ID: 10458130
[TBL] [Abstract][Full Text] [Related]
19. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.
Zalewski B
World J Gastroenterol; 2004 Feb; 10(4):583-5. PubMed ID: 14966921
[TBL] [Abstract][Full Text] [Related]
20. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
